Prostate Cancer Therapeutics Market Size, Share & Trends Report, 2022-2030

According to the latest research study, the demand of  global Prostate Cancer Therapeutics market gathered revenue around USD 15.2 billion in 2021 and market is set to grow USD 24.9 billion by the end of 2030 and is estimated to expand at a modest CAGR of 9.4% during the prediction period 2022 to 2030.

Download Free Sample@ https://www.novaoneadvisor.com/report/sample/6340

Growth Factors:

According to the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate cancer in their lifetime. As per Cancer Research, a government institute, in the UK, 46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died in 2014.

Supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and on-time treatment and assists in deciding treatment regimens. In addition, major players including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson & Johnson are focusing on the development of effective and safe therapeutic products to treat tumors. Moreover, these players have various established brands such as Zytiga, Xtandi, Eligard, Taxotere, Provenge, and Xofigo, which hold a strong position in the market. In addition, there are many drugs in the pipeline such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), and ODM-201 (Orion and Bayer), which are in their phase 3 studies and are expected to enter the market during the forecast period. In addition, patents of many existing products are expiring during the forecast period. As a result, generic products are anticipated to penetrate the market. All these factors together are expected to propel growth.

In Canada, Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer through an online portal. This portal provides detailed information regarding symptoms, diagnosis, and commercially available treatment options. Such portals offer free access to people all around the world, which is resulting in growth.

Report Scope of the Prostate Cancer Therapeutics Market

Download Full Report@ https://www.novaoneadvisor.com/report/checkout/6340

Regional Insights

North America was leading the global market with the largest revenue share in 2016. Rising prevalence and high mortality rate of prostate cancer in the U.S. are the primary reasons responsible for the dominance of North America in the market. Furthermore, this region is witnessing high investment in R&D for the development of newer immunotherapies and targeted drug therapies to treat such tumors.

Asia Pacific is anticipated to be the fastest-growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.

Adoption of new technologies, improving healthcare infrastructure, and growing investments by market players for the development of immunotherapies and targeted therapies, which is resulting in a strong pipeline, are some of the factors expected to trigger growth in the Asia Pacific region. In China, major players are collaborating with local & government institutions such as the Chinese Urological Association to conduct research activities for the treatment of prostate cancer. As a result, Asia Pacific is projected to be the fastest-growing region.

Key Points of the Global Prostate Cancer Therapeutics Market Report:

• The report provides a basic overview of the Prostate Cancer Therapeutics industry including its definition, applications, and manufacturing technology.
• The report also explores the major international players in detail. In this part, the report presents the company profile, product specifications, capacity, and production value up to‘2030 year’, along with the market shares for each company.
• Through the statistical analysis, the study depicts the global market for Prostate Cancer Therapeutics including capacity, production, production value, cost/profit, and supply/demand from an international perspective.
• Considering segmentation, the market is divided in terms of product, end-use, company, region, and other important aspects. Each of these categories forms an important base point for the competitive landscape analysis.
• The report then estimates the market development and trends of the Prostate Cancer Therapeutics industry up to 2030.
• The report hints at crucial information associated with new market developments being undertaken in the Prostate Cancer Therapeutics industry before evaluating its feasibility.

Read also: https://www.uswebwire.com/lyophilized-injectable-market/

Competitive Analysis

The report covers major players operating in the market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. Key players of the global Prostate Cancer Therapeutics market are included as given below:

Some of the prominent players in the Prostate Cancer Therapeutics market include:

• Amgen, Inc.
• Johnson & Johnson (Janssen Biotech, Inc.)
• Pfizer, Inc.
• AstraZeneca
• AbbVie, Inc.
• Bayer AG
• Ipsen Group
• Sanofi
• Endo Pharmaceuticals, Inc.
• Sanpower Group (Dendreon Corporation).

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

• Global Prostate Cancer Therapeutics Market, by Therapy
  • Hormone Therapy
    • Luteinizing Hormone-releasing Hormone Analogs
    • Luteinizing Hormone-releasing Hormone Antagonists
    • Antiandrogens
  • Chemotherapy
    • Systemic Chemotherapy
    • Regional Chemotherapy
  • Biologic Therapy
  • Targeted Therapy
• Global Prostate Cancer Therapeutics Market, by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online sales
  • Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Reasons to Purchase this Report:

• Estimates Prostate Cancer Therapeutics development trends with SWOT analysis
• Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players
• Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion
• Market dynamics scenario, along with growth opportunities for players in the years to come
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects

Click Here to View Full Report Table of Contents

Download Full Report@ https://www.novaoneadvisor.com/report/checkout/6340

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team sales@novaoneadvisor.com who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1 9197 992 333 to share your research requirements.